STAT3 and neoplasm: Pull-down experiments with an activity-based probe (ABP) of SFN [21] in HBCx34 PDX tumor cells confirmed direct interaction of SFN with STAT3 in both antiestrogen and vehicle-treated tumors (Fig. 4c), establishing STAT3 as the likely target of SFX-01.